Leo Pharma wants to be first in US with hand eczema treatment
After securing fast-track status from the FDA, Leo Pharma hopes to become the first company in the US to specifically address chronic hand eczema, for which there is no treatment in the country.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.